Erik Widerlöv

2.6k total citations · 1 hit paper
39 papers, 2.1k citations indexed

About

Erik Widerlöv is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Erik Widerlöv has authored 39 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cellular and Molecular Neuroscience, 12 papers in Molecular Biology and 9 papers in Cognitive Neuroscience. Recurrent topics in Erik Widerlöv's work include Neuropeptides and Animal Physiology (12 papers), Receptor Mechanisms and Signaling (10 papers) and Sleep and Wakefulness Research (9 papers). Erik Widerlöv is often cited by papers focused on Neuropeptides and Animal Physiology (12 papers), Receptor Mechanisms and Signaling (10 papers) and Sleep and Wakefulness Research (9 papers). Erik Widerlöv collaborates with scholars based in Sweden, United States and Hungary. Erik Widerlöv's co-authors include Charles B. Nemeroff, Garth Bissette, Ingvar Karlsson, Kurt Eklund, Peter T. Loosen, Wylie Vale, Clinton D. Kilts, Claes Wahlestedt, Rolf Ekman and Markus Heilig and has published in prestigious journals such as Science, Biological Psychiatry and Annals of the New York Academy of Sciences.

In The Last Decade

Erik Widerlöv

38 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

1984 1.2k citations Charles B. Nemeroff, Erik Widerlöv et al. profile →

Peers

Erik Widerlöv

CMN

S Makino Japan

Elizabeth A. Young United States

Bruce S. McEwen United States

EB De Souza United States

Florian Holsboer Germany

Daniela Eser Germany

Flavia di Michele Italy

Florian Holsboer Germany

Nitsan Kozlovsky Israel

Annette Sonntag Germany

S Makino Japan

Erik Widerlöv

1.2k ×1.1

888 ×1.1

CMN

365 ×0.7

540 ×1.1

232 ×0.5

Citations per year, relative to Erik Widerlöv Erik Widerlöv (= 1×) peers S Makino

Countries citing papers authored by Erik Widerlöv

Since Specialization

Citations

This map shows the geographic impact of Erik Widerlöv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Widerlöv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Widerlöv more than expected).

Fields of papers citing papers by Erik Widerlöv

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Widerlöv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Widerlöv. The network helps show where Erik Widerlöv may publish in the future.

Co-authorship network of co-authors of Erik Widerlöv

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Widerlöv. A scholar is included among the top collaborators of Erik Widerlöv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Widerlöv. Erik Widerlöv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kammen, Daniël P. van, Erik Widerlöv, Thomas C. Neylan, et al.. (1992). Delta Sleep-Inducing-Peptide-Like Immunoreactivity (DSIP-LI) and Delta Sleep in Schizophrenic Volunteers. SLEEP. 15(6). 519–525. 5 indexed citations

Widerlöv, Erik, et al.. (1991). Pharmacokinetics and effects on prolactin of remoxipride in patients with tardive dyskinesia. Psychopharmacology. 103(1). 46–49. 7 indexed citations

Wallin, Anders, Arvid Carlsson, Rolf Ekman, et al.. (1991). Hypothalamic monoamines and neuropeptides in dementia. European Neuropsychopharmacology. 1(2). 165–168. 23 indexed citations

Bissette, Garth, et al.. (1991). Alterations in regional brain neurotensin concentrations produced by atypical antipsychotic drugs. Regulatory Peptides. 32(2). 193–201. 24 indexed citations

Vécsei, László, et al.. (1990). Lumbar cerebrospinal fluid concentrations of somatostatin and neuropeptide y in multiple sclerosis. Brain Research Bulletin. 25(3). 411–413. 14 indexed citations

Vécsei, László & Erik Widerlöv. (1990). Effects of somatostatin-28 and some of its fragments and analogs on open-field behavior, barrel rotation, and shuttle box learning in rats. Psychoneuroendocrinology. 15(2). 139–145. 14 indexed citations

Vécsei, László, Erik Widerlöv, Rolf Ekman, & Christer Alling. (1990). Dose- and time-response effects of pantethine on open-field behavior, and on central neurotransmission in rats. Pharmacology Biochemistry and Behavior. 35(1). 165–170. 4 indexed citations

Vécsei, László & Erik Widerlöv. (1990). Preclinical and clinical studies with cysteamine and pantethine related to the central nervous system. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 14(6). IN1–862. 23 indexed citations

Vécsei, László & Erik Widerlöv. (1990). Preclinical and clinical studies with somatostatin related to the central nervous system. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 14(4). 473–502. 36 indexed citations

10.

Vécsei, László, et al.. (1989). Comparative studies of somatostatin-14 and some of its fragments on passive avoidance behavior, open field activity and on barrel rotation phenomenon in rats. Peptides. 10(6). 1153–1157. 24 indexed citations

11.

Wahlestedt, Claes, Rolf Ekman, & Erik Widerlöv. (1989). Neuropeptide Y (NPY) and the central nervous system: Distribution effects and possible relationship to neurological and psychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 13(1-2). 31–54. 76 indexed citations

12.

Bjartell, Anders, María G. Castro, Rolf Ekman, et al.. (1989). Immunoreactive Delta Sleep-Inducing Peptide Secretion from Mouse Dissociated, Anterior Pituitary Cells: Regulation by Corticotropin-Releasing Factor and Arginine Vasopressin. Neuroendocrinology. 50(5). 564–569. 13 indexed citations

13.

Wahlestedt, Claes, Rolf Ekman, Markus Heilig, & Erik Widerlöv. (1989). Effects of psychoactive drugs on delta sleep-inducing peptide concentrations in rat brain. European Journal of Pharmacology. 159(3). 285–289. 1 indexed citations

14.

Vécsei, László, Christer Alling, Markus Heilig, & Erik Widerlöv. (1989). Effects of cysteamine and pantethine on open-field behavior, hypothalamic catecholamine concentrations, and somatostatin-induced barrel rotation in rats. Pharmacology Biochemistry and Behavior. 32(3). 629–635. 10 indexed citations

15.

Heilig, Markus, Claes Wahlestedt, Rolf Ekman, & Erik Widerlöv. (1988). Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain. European Journal of Pharmacology. 147(3). 465–467. 104 indexed citations

16.

Widerlöv, Erik. (1988). A Critical Appraisal of CSF Monoamine Metabolite Studies in Schizophrenia. Annals of the New York Academy of Sciences. 537(1). 309–323. 22 indexed citations

17.

Lindström, Leif, et al.. (1988). Reduced CSF neurotensin concentration in drug-free schizophrenic patients. Schizophrenia Research. 1(1). 55–59. 60 indexed citations

18.

Lesch, Klaus‐Peter, Erik Widerlöv, Rolf Ekman, et al.. (1988). Delta sleep-inducing peptide response to human corticotropin-releasing hormone (CRH) in major depressive disorder. Biological Psychiatry. 24(2). 162–172. 17 indexed citations

19.

Heilig, Markus, Claes Wahlestedt, & Erik Widerlöv. (1988). Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with α-adrenoceptors. European Journal of Pharmacology. 157(2-3). 205–213. 92 indexed citations

20.

Widerlöv, Erik & Rolf Sjöström. (1975). Effekter av TRH vid endogen depression. Nordisk Psykiatrisk Tidsskrift. 29(6). 503–512. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact